tumorsMalignant tumoursMalignant tumours2224-50572587-6813Rosoncoweb10.18027/2224-5057-2019-9-1-38-41tumors-614Research ArticleОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯORIGINAL REPORTSЗначение позитронно-эмиссионной томографии и магнитно-резонансной томографии малого таза в планировании оперативного лечения больных с раком предстательной железы группы высокого рискаThe significance of pelvis positron emission tomography and magnetic resonance tomography for surgical planning in patients with high risk prostate cancerШихзадаевМ. Ш.ShikhzadaevM. Sh.

Махмуд Ш. Шихзадаев, врач онколог-уролог, аспирант отделения онкоурологиии

Санкт-Петербург

 

Makhmud Sh. Shikhzadaev, urologic oncologist, postgraduate student of the Department of Urologic Oncology 

Saint Petersburg

makhmud.shikhzadaev@mail.ruШкольникМ. И.ShkolnikM. I.

Михаил И. Школьник, доктор медицинских наук, врач онколог-уролог, руководитель отделения онкоурологии 

Санкт-Петербург

Mikhail I. Shkolnik, MD, PhD, DSc, urologic oncologist, Head of the Department of Urologic Oncology

Saint Petersburg

СтанжевскийА. А.StanjevskiyA. A.

Андрей А. Станжевский, доктор медицинских наук, врач-радиолог, ведущий специалист по лучевой диагностике и лучевой терапии, заместитель директора по научной работе

Санкт-Петербург

Andrey A. Stanjevskiy, MD, PhD, DSc, radiologist, leading specialist in radiology and radiation therapy, Deputy Head for Scientific Issues 

Saint Petersburg

БогомоловО. А.BogomolovO. A.

Олег А. Богомолов, врач онколог-уролог отделения оперативного лечения онкоурологических и онкогинекологических заболеваний 

Санкт-Петербург

Oleg A. Bogomolov, urologic oncologist of the Department of Urologic Oncology and Gynecologic Oncology Surgery 

Saint Petersburg

ДолбовА. Л.DolbovA. L.

Артем Л. Долбов, врачрентгенолог отделения радиоизотопной позитронно-эмиссионной томографии 

Санкт-Петербург

Artem L. Dolbov, radiologist of the Department of Positron Emission Tomography

Saint Petersburg

ФГБУ «Российский научный центр радиологии и хирургических технологий им. академика А. М. Гранова» Минздрава РоссииРоссияFederal State Budgetary Institution Russian Research Center for Radiology and Surgical Technologies named after Academician A. M. Granov of the Ministry of Health of RussiaRussian Federation201910042019913841Copyright © Шихзадаев М.Ш., Школьник М.И., Станжевский А.А., Богомолов О.А., Долбов А.Л., 20192019Шихзадаев М.Ш., Школьник М.И., Станжевский А.А., Богомолов О.А., Долбов А.Л.Shikhzadaev M.S., Shkolnik M.I., Stanjevskiy A.A., Bogomolov O.A., Dolbov A.L.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.malignanttumors.org/jour/article/view/614

В статье рассмотрена диагностическая ценность использования ПЭТ/ КТ в планировании лечения больных раком предстательной железы из группы высокого риска.

The article concerns the diagnostic value of PET/CT scan for surgical planning in patients with high‑risk prostate cancer.

рак предстательной железыпростатический специфический антигенпозитронно-эмиссионная томографияprostate cancerprostate specific antigenpositron emission tomographyReferencesШихзадаев М. Ш, Школьник М. И, Жаринов Г. М, Богомолов О. А, Прохоров Д. Г. Современные подходы в лечении местно распространенного рака предстательной железы // Вопросы онкологии, 2018. Том 64, № 4.Шихзадаев М. Ш, Школьник М. И, Жаринов Г. М, Богомолов О. А, Прохоров Д. Г. Современные подходы в лечении местно распространенного рака предстательной железы // Вопросы онкологии, 2018. Том 64, № 4.Al Monajjed R. Prostate cancer screening: controversies and suggested solutions/R. Al Monajjed, C. Arsov, P. Albers // Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. — 2018. — doi: 10.1007/s00103-018-2840-x.Al Monajjed R. Prostate cancer screening: controversies and suggested solutions/R. Al Monajjed, C. Arsov, P. Albers // Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. — 2018. — doi: 10.1007/s00103-018-2840-x.Sensitivity, Specificity, and Predictors of Positive 68 Ga Prostate specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta analysis/M. Perera, N. Papa, D. Christidis [et al.] // Eur Urol. — 2016. — Vol. 70, No. 6. — P. 926–937. — doi: 10.1016/j.eururo.2016.06.021.Sensitivity, Specificity, and Predictors of Positive 68 Ga Prostate specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta analysis/M. Perera, N. Papa, D. Christidis [et al.] // Eur Urol. — 2016. — Vol. 70, No. 6. — P. 926–937. — doi: 10.1016/j.eururo.2016.06.021.Diagnostic Efficacy of (68) Gallium PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer/T. Maurer, J. E. Gschwend, I. Rauscher [et al.] // J Urol. — 2016. — Vol. 195, No. 5. — P. 1436–1443. — doi: 10.1016/j.juro.2015.12.025.Diagnostic Efficacy of (68) Gallium PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer/T. Maurer, J. E. Gschwend, I. Rauscher [et al.] // J Urol. — 2016. — Vol. 195, No. 5. — P. 1436–1443. — doi: 10.1016/j.juro.2015.12.025.Jadvar H. Positron emission tomography in imaging evaluation of staging, restaging, treatment response, and prognosis in prostate cancer/H. Jadvar // Abdom Radiol (NY). — 2016. — Vol. 41, No. 5. — P. 889–898. — doi: 10.1007/s00261-015-0563-0.Jadvar H. Positron emission tomography in imaging evaluation of staging, restaging, treatment response, and prognosis in prostate cancer/H. Jadvar // Abdom Radiol (NY). — 2016. — Vol. 41, No. 5. — P. 889–898. — doi: 10.1007/s00261-015-0563-0.68 Ga PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer/A. Herlemann, V. Wenter, A. Kretschmer [et al.] // Eur Urol. — 2016. — Vol. 70, No. 4. — P. 553–557. — doi: 10.1016/j.eururo.2015.12.051.68 Ga PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer/A. Herlemann, V. Wenter, A. Kretschmer [et al.] // Eur Urol. — 2016. — Vol. 70, No. 4. — P. 553–557. — doi: 10.1016/j.eururo.2015.12.051.Clinical impact of 68 Ga prostate specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach/S. Albisinni, C. Artigas, F. Aoun [et al.] // BJU Int. — 2017. — Vol. 120, No. 2. — P. 197–203. — doi: 10.1111/bju.13739.Clinical impact of 68 Ga prostate specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach/S. Albisinni, C. Artigas, F. Aoun [et al.] // BJU Int. — 2017. — Vol. 120, No. 2. — P. 197–203. — doi: 10.1111/bju.13739.The Role of Positron Emission Tomography With (68) Gallium (Ga) — Labeled Prostate specific Membrane Antigen (PSMA) in the Management of Patients With Organ confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and After Radical Prostatectomy/B. P. Rai, R. P. Baum, A. Patel [et al.] // Urology. — 2016. — Vol. 95. — P. 11–15. — doi: 10.1016/urology.2015.12.048.The Role of Positron Emission Tomography With (68) Gallium (Ga) — Labeled Prostate specific Membrane Antigen (PSMA) in the Management of Patients With Organ confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and After Radical Prostatectomy/B. P. Rai, R. P. Baum, A. Patel [et al.] // Urology. — 2016. — Vol. 95. — P. 11–15. — doi: 10.1016/urology.2015.12.048.Prospective evaluation of 68 Gallium prostate specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer/P. J. van Leeuwen, L. Emmett, B. Ho [et al.] // BJU Int. — 2017. — Vol. 119, No. 2. — P. 209–215. — doi: 10.1111/bju.13 540.Prospective evaluation of 68 Gallium prostate specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer/P. J. van Leeuwen, L. Emmett, B. Ho [et al.] // BJU Int. — 2017. — Vol. 119, No. 2. — P. 209–215. — doi: 10.1111/bju.13 540.Nonspecific Uptake of 68 Ga Prostate Specific Membrane Antigen in Diseases other than Prostate Malignancy on Positron Emission Tomography/Computed Tomography Imaging: A Pictorial Assay and Review of Literature/D. Malik, A. Sood, B. R. Mittal [et al.] // Indian J Nucl Med. — 2018. — Vol. 33, No. 4. — P. 317–325. — doi: 10.4103/ijnm.IJNM_81_18.Nonspecific Uptake of 68 Ga Prostate Specific Membrane Antigen in Diseases other than Prostate Malignancy on Positron Emission Tomography/Computed Tomography Imaging: A Pictorial Assay and Review of Literature/D. Malik, A. Sood, B. R. Mittal [et al.] // Indian J Nucl Med. — 2018. — Vol. 33, No. 4. — P. 317–325. — doi: 10.4103/ijnm.IJNM_81_18.Assessment of 68 Ga PSMA 11 PET positivity predictive factors in prostate cancer/A. L. Gutiérrez Cardo, A. Pérez Duarte, S. F. García Argüello [et al.] // Rev Esp Med Nucl Imagen Mol. — 2018. — doi: 10.1016/j.remn.2018.09.006.Assessment of 68 Ga PSMA 11 PET positivity predictive factors in prostate cancer/A. L. Gutiérrez Cardo, A. Pérez Duarte, S. F. García Argüello [et al.] // Rev Esp Med Nucl Imagen Mol. — 2018. — doi: 10.1016/j.remn.2018.09.006.Prostate imaging features that indicate benign or malignant pathology on biopsy/C. E. Lovegrove, M. Matanhelia, J. Randeva [et al.] // Transl Androl Urol. — 2018. — No. 7, Suppl. 4. — P. S420 S435. — doi: 10.21037/tau.2018.07.06.Prostate imaging features that indicate benign or malignant pathology on biopsy/C. E. Lovegrove, M. Matanhelia, J. Randeva [et al.] // Transl Androl Urol. — 2018. — No. 7, Suppl. 4. — P. S420 S435. — doi: 10.21037/tau.2018.07.06.Ланг Т. А. Как описывать статистику в медицине/Т. А. Ланг, М. Сесик; пер. с англ. под ред. В. П. Леонова. — М.: Практическая медицина, 2011. — 480 с.Ланг Т. А. Как описывать статистику в медицине/Т. А. Ланг, М. Сесик; пер. с англ. под ред. В. П. Леонова. — М.: Практическая медицина, 2011. — 480 с.Jansson K. F. et al. Concordance of tumor differentiation among brothers with prostate cancer // European urology. –2012. — T.62. №. 4. — C. 656–661.Jansson K. F. et al. Concordance of tumor differentiation among brothers with prostate cancer // European urology. –2012. — T.62. №. 4. — C. 656–661.Ferlay J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 // International journal of cancer. — 2015. — T. 136. — №. 5.Ferlay J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 // International journal of cancer. — 2015. — T. 136. — №. 5.

The authors declare that there are no conflicts of interest present.